Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: 1-Year Results From the Disrupt CAD III Study by Dean J. Kereiakes, MD, Jonathan M. Hill, MD, Richard A. Shlofmitz, MD, Andrew J. Klein, MD, Robert F. Riley, MD, Matthew J. Price, MD, Howard C. Herrmann, MD, William Bachinsky, MD, Ron Waksman, MD, Gregg W. Stone, MD

Get full text

Racial and Ethnic Disparities in the Use and Outcomes With WATCHMAN FLX: A SURPASS Analysis of the NCDR Left Atrial Appendage Occlusion Registry by Oluseun O. Alli, Jalaj Garg, Brian C. Boursiquot, Samir R. Kapadia, Robert W. Yeh, Matthew J. Price, Jonathan P. Piccini, Devi G. Nair, Jonathan C. Hsu, Douglas N. Gibson, Dominic Allocco, Thomas Christen, Brad Sutton, James V. Freeman

Get full text

Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial by Shephal K. Doshi, Saibal Kar, Ashish Sadhu, Rodney Horton, Jose Osorio, Christopher Ellis, James Stone, Manish Shah, Srinivas R. Dukkipati, Stuart Adler, Devi G. Nair, Jamie Kim, Oussama Wazni, Matthew J. Price, David R. Holmes, Robert Shipley, Thomas Christen, Dominic J. Allocco, Vivek Y. Reddy

Get full text

Sex-Specific Outcomes After Coronary Intravascular Lithotripsy: A Patient-Level Analysis of the Disrupt CAD Studies by Yasin Hussain, MD, Kathleen E. Kearney, MD, J. Dawn Abbott, MD, Dean J. Kereiakes, MD, Carlo Di Mario, MD, PhD, Shigeru Saito, MD, Ecaterina Cristea, MD, Robert F. Riley, MD, Jean Fajadet, MD, Richard A. Shlofmitz, MD, Ziad A. Ali, MD, DPhil, Andrew J. Klein, MD, Matthew J. Price, MD, Jonathan M. Hill, MD, Gregg W. Stone, MD, Alexandra J. Lansky, MD

Get full text